MindLight™
Major Depressive Disorder (MDD) - Prediction of SSRI (antidepressant) response
Key Facts
About Circular Genomics
Circular Genomics is a biotechnology company revolutionizing precision psychiatry and neurology with its proprietary circular RNA platform. The company's mission is to make brain disorders measurable and manageable by developing blood-based diagnostic tests that offer a real-time view of brain biology, enabling personalized treatment decisions. Its lead product, MindLight™, is a commercially available test for predicting SSRI response in depression, and it is actively building a pipeline for Alzheimer's disease and other neurodegenerative conditions. Backed by exclusive IP licenses from leading research institutions and a distinguished scientific advisory board, Circular Genomics is positioned to address significant unmet needs in brain health.
View full company profile